Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 636

1.

APOE epsilon4 and cognitive decline in older stroke patients with early cognitive impairment.

Ballard CG, Morris CM, Rao H, O'Brien JT, Barber R, Stephens S, Rowan E, Gibson A, Kalaria RN, Kenny RA.

Neurology. 2004 Oct 26;63(8):1399-402.

PMID:
15505155
[PubMed - indexed for MEDLINE]
2.

Association between ApoE epsilon4 and cognitive impairment after stroke.

Wagle J, Farner L, Flekkøy K, Wyller TB, Sandvik L, Eiklid KL, Fure B, Stensrød B, Engedal K.

Dement Geriatr Cogn Disord. 2009;27(6):525-33. doi: 10.1159/000223230. Epub 2009 Jun 4.

PMID:
19494491
[PubMed - indexed for MEDLINE]
3.

Stroke and apolipoprotein E epsilon4 are independent risk factors for cognitive decline: A population-based study.

Dik MG, Deeg DJ, Bouter LM, Corder EH, Kok A, Jonker C.

Stroke. 2000 Oct;31(10):2431-6.

PMID:
11022076
[PubMed - indexed for MEDLINE]
Free Article
4.

Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.

Devanand DP, Pelton GH, Zamora D, Liu X, Tabert MH, Goodkind M, Scarmeas N, Braun I, Stern Y, Mayeux R.

Arch Neurol. 2005 Jun;62(6):975-80.

PMID:
15956169
[PubMed - indexed for MEDLINE]
5.

Cognitive domain decline in healthy apolipoprotein E epsilon4 homozygotes before the diagnosis of mild cognitive impairment.

Caselli RJ, Reiman EM, Locke DE, Hutton ML, Hentz JG, Hoffman-Snyder C, Woodruff BK, Alexander GE, Osborne D.

Arch Neurol. 2007 Sep;64(9):1306-11.

PMID:
17846270
[PubMed - indexed for MEDLINE]
6.

The association between delirium and the apolipoprotein E epsilon4 allele in the elderly.

van Munster BC, Korevaar JC, de Rooij SE, Levi M, Zwinderman AH.

Psychiatr Genet. 2007 Oct;17(5):261-6.

PMID:
17728664
[PubMed - indexed for MEDLINE]
7.

The role of APOE-epsilon4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging.

Bretsky P, Guralnik JM, Launer L, Albert M, Seeman TE; MacArthur Studies of Successful Aging.

Neurology. 2003 Apr 8;60(7):1077-81.

PMID:
12682309
[PubMed - indexed for MEDLINE]
8.

[Dementia and cognitive impairment pattern: its association with epsilon4 allele of apolipoprotein E gene].

Rosich-Estragó M, Figuera-Terré L, Mulet-Pérez B, Arrufat-Cardús MT, Pascual San Emeterio A, Arbeola-Rigau I, Labad-Alquézar A, Vilella-Cuadrada E.

Rev Neurol. 2004 May 1-15;38(9):801-7. Spanish.

PMID:
15152345
[PubMed - indexed for MEDLINE]
Free Article
9.

APOE-epsilon4 is associated with memory decline in cognitively impaired elderly.

Dik MG, Jonker C, Bouter LM, Geerlings MI, van Kamp GJ, Deeg DJ.

Neurology. 2000 Apr 11;54(7):1492-7.

PMID:
10751265
[PubMed - indexed for MEDLINE]
10.

Memory complaints and APOE-epsilon4 accelerate cognitive decline in cognitively normal elderly.

Dik MG, Jonker C, Comijs HC, Bouter LM, Twisk JW, van Kamp GJ, Deeg DJ.

Neurology. 2001 Dec 26;57(12):2217-22.

PMID:
11756600
[PubMed - indexed for MEDLINE]
11.

Nocturnal sleep apnea/hypopnea is associated with lower memory performance in APOE epsilon4 carriers.

O'Hara R, Schröder CM, Kraemer HC, Kryla N, Cao C, Miller E, Schatzberg AF, Yesavage JA, Murphy GM Jr.

Neurology. 2005 Aug 23;65(4):642-4.

PMID:
16116137
[PubMed - indexed for MEDLINE]
12.

APOE and cognitive decline in preclinical Alzheimer disease and non-demented aging.

Bunce D, Fratiglioni L, Small BJ, Winblad B, Bäckman L.

Neurology. 2004 Sep 14;63(5):816-21.

PMID:
15365129
[PubMed - indexed for MEDLINE]
13.

Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.

Hoyt BD, Massman PJ, Schatschneider C, Cooke N, Doody RS.

Arch Neurol. 2005 Mar;62(3):454-9.

PMID:
15767511
[PubMed - indexed for MEDLINE]
14.

Association between apolipoprotein E ε4 and longitudinal cognitive decline: nested case-control study among chinese community-dwelling elders.

Ma F, Wang J, Miao R, Zhao W, Wang Q.

Neuropsychobiology. 2011;64(2):102-9. doi: 10.1159/000324991. Epub 2011 Jun 21.

PMID:
21701228
[PubMed - indexed for MEDLINE]
15.

The APOE epsilon4 allele is associated with decline on delayed recall performance in community-dwelling older adults.

O'Hara R, Yesavage JA, Kraemer HC, Mauricio M, Friedman LF, Murphy GM Jr.

J Am Geriatr Soc. 1998 Dec;46(12):1493-8.

PMID:
9848808
[PubMed - indexed for MEDLINE]
16.

Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population.

Yip AG, Brayne C, Easton D, Rubinsztein DC; Medical Research Council Cognitive Function Ageing Study (MRC CFAS).

J Med Genet. 2002 Sep;39(9):639-43.

PMID:
12205106
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Association between apolipoprotein E epsilon4 and the rate of cognitive decline in community-dwelling elderly individuals with and without dementia.

Jonker C, Schmand B, Lindeboom J, Havekes LM, Launer LJ.

Arch Neurol. 1998 Aug;55(8):1065-9.

PMID:
9708956
[PubMed - indexed for MEDLINE]
18.

The joint effect of apolipoprotein E epsilon4 and MRI findings on lower-extremity function and decline in cognitive function.

Carmelli D, DeCarli C, Swan GE, Kelly-Hayes M, Wolf PA, Reed T, Guralnik JM.

J Gerontol A Biol Sci Med Sci. 2000 Feb;55(2):M103-9.

PMID:
10737693
[PubMed - indexed for MEDLINE]
19.

Fourteen-year longitudinal study of vascular risk factors, APOE genotype, and cognition: the ARIC MRI Study.

Knopman DS, Mosley TH, Catellier DJ, Coker LH; Atherosclerosis Risk in Communities Study Brain MRI Study.

Alzheimers Dement. 2009 May;5(3):207-14. doi: 10.1016/j.jalz.2009.01.027. Epub 2009 Apr 11.

PMID:
19362884
[PubMed - indexed for MEDLINE]
20.

APOE alleles predict the rate of cognitive decline in Alzheimer disease: a nonlinear model.

Martins CA, Oulhaj A, de Jager CA, Williams JH.

Neurology. 2005 Dec 27;65(12):1888-93.

PMID:
16380608
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk